$30.00Average Price Target
The highest estimate is 50.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow UPB. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases. Verekitug has advanced into three separate world-wide, placebo-controlled, randomized Phase 2 clinical trials, two completed in chronic rhinosinusitis with nasal polyps (CRSwNP) and severe asthma, and one ongoing in chronic obstructive pulmonary disease (COPD).
FAQs
What is Upstream Bio stock price today?▼
The current price of UPB is $3.41 USD — it has increased by +4.28% in the past 24 hours. Watch Upstream Bio stock price performance more closely on the chart.
What is Upstream Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Upstream Bio stocks are traded under the ticker UPB.
Is Upstream Bio stock price growing?▼
UPB stock has risen by +24% compared to the previous week, the month change is a -32.34% fall, over the last year Upstream Bio has showed a -86.81% decrease.
What is Upstream Bio market cap?▼
Today Upstream Bio has the market capitalization of 186.77M
When is the next Upstream Bio earnings date?▼
Upstream Bio is going to release the next earnings report on November 5, 2026.
What were Upstream Bio earnings last quarter?▼
UPB earnings for the last quarter are -0.73 USD per share, whereas the estimation was -0.74 USD resulting in a +1.94% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Upstream Bio revenue for the last year?▼
Upstream Bio revenue for the last year amounts to 2.85M USD.
What is Upstream Bio net income for the last year?▼
UPB net income for the last year is -143.44M USD.
How many employees does Upstream Bio have?▼
As of November 2, 2026, the company has 75 employees.
In which sector is Upstream Bio located?▼
Upstream Bio operates in the Health & Wellness sector.
When did Upstream Bio complete a stock split?▼
Upstream Bio has not had any recent stock splits.
Where is Upstream Bio headquartered?▼
Upstream Bio is headquartered in WALTHAM, United States.